Marc F. Pelletier is a Scientist-Entrepreneur with over 30 years of research and operational experience in the life sciences and is currently serving as Chief Executive Officer of Gardiner Healthcare. Dr. Pelletier founded his first company, Aeromics, as a James Hudson Brown-Alexander B. Coxe Fellow at Yale School of Medicine serving as CEO from 2008-2019. Overseeing strategic and scientific operations, he led Aeromics' drug discovery and development program from bench to clinic, developing the first clinical-stage Aquaporin inhibitor to treat diseases of water imbalance, starting with brain swelling or cerebral edema. In 2015, he co-founded Iridia, Inc., a company developing the first DNA-based computer hard drive or molecular information storage technology (MIST). 

Dr. Pelletier has extensive training in the life sciences having completed several post-docs while at Yale in the Departments of Genetics, Biophysics & Biochemistry, lastly in the Department of Cellular & Molecular Physiology. He received his Ph.D. in Cell Biology from McGill University, and both an M.Sc. in Plant Genetics and B.Sc. in Biology and Economics from Concordia University in Montreal. On a lighter side, Dr. Pelletier is an active martial artist with two black belts, is a 4th dan Master in Taekwondo, and serves as an American Athletics Union (AAU) Official in his free time.